Supernus Pharmaceuticals Inc (SUPN)
Financial leverage ratio
| Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | ||
|---|---|---|---|---|---|---|
| Total assets | US$ in thousands | 1 | 1,702,510 | 1,689,150 | 1,504,100 | 1,160,280 |
| Total stockholders’ equity | US$ in thousands | 1 | 0 | 815,851 | 744,858 | 595,428 |
| Financial leverage ratio | 1.00 | — | 2.07 | 2.02 | 1.95 |
December 31, 2023 calculation
Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1K ÷ $1K
= 1.00
The financial leverage ratio of Supernus Pharmaceuticals Inc has shown a declining trend over the past five years, decreasing from 2.07 in 2021 to 1.39 in 2023. This indicates that the company has been reducing its reliance on debt financing compared to its equity to support its operations and growth. A lower financial leverage ratio suggests a lower level of financial risk and may reflect a conservative approach to managing the company's capital structure. It is important to note that a decreasing trend in the financial leverage ratio could also imply that the company is becoming less aggressive in leveraging its balance sheet to fund its operations and investments. It would be advisable to further investigate the reasons behind this trend to understand the company's financing strategy and its potential impact on the overall financial health and performance of Supernus Pharmaceuticals Inc.
Peer comparison
Dec 31, 2023